If you've been spending time with Dispatch and feeling that Malevola's practically humming with early 1990s supermodel energy ...

Target is turning heads this holiday season with its unconventional marketing campaign featuring a "weirdly hot" Santa Claus named Kris. In a playful departure from traditional holiday advertising, ...

Gilead Sciences (NASDAQ:GILD) has discontinued a Phase 1 trial for GS-1219, a long-acting subcutaneously delivered treatment targeting HIV infections, according to an update on the federal register on ...

The penultimate week of the regular season brought some impressive games on football fields all across the Jackson area. From some of those big games, we have gathered up some of the biggest ...

Sexy jeans, fizzy drinks, and the most memorable "diabeetus" spokesman to hit the small screen. These TV commercial actors might be gone, but they're definitely not forgotten. Senate Republicans defy ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 20th European AIDS Conference (EACS) to be held in Paris, France from October 15-18. As the leader in HIV ...

Gilead has settled patent disputes with three generic companies for Biktarvy, per a Yahoo Finance report. Gilead settlement agreements are with Lupin, Cipla and Laurus Labs, who had filed abbreviated ...

Commercial litigation is notoriously expensive. It’s not unusual for a case to take years and cost hundreds of thousands of dollars in legal bills, just to get to trial. That financial barrier causes ...

This is read by an automated voice. Please report any issues or inconsistencies here. Streaming services are now required to turn the dial down on commercial advertisements that blare louder than ...

Gilead Sciences said it has reached settlements with multiple drugmakers that had sought to market generic versions of Biktarvy, its treatment for HIV, delaying generic competition for more than a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new commercial building has ...